Evaluation of Activity Levels, Inflammatory Markers, and Overall Wellness. (114-012)
Evaluation of Activity Levels, Inflammatory Markers, and Overall Wellness. A Randomized, Double-blind, Placebo-controlled Clinical Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oregon
-
Klamath Falls, Oregon, United States, 97601
- NIS Labs
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy adults of either gender;
- 35-75 years old;
- Chronic joint/muscle related pain for at least past 6 months;
- Body mass index (BMI) at or below 34.9 kg/m2.
Exclusion Criteria:
- Bariatric surgery;
- Diagnosed with diabetes Type I;
- Taking medication for diabetes Type II;
- Known serious chronic health condition;
- Serious active illness within past 12 months;
- Major surgery within the past 3 months;
- Major trauma within the past 3 months;
- Alcohol consumption of more than four standard units/day (for example more than four regular 12 oz beers (5% alcohol), four small 5-oz glasses of wine (12% alcohol), or four 1.5 oz shots of 80-proof spirits), or more than 28 units per week;
- Daily consumption of Nopalea or similar juice products during the past month;
- Currently taking anti-inflammatory nutritional supplements judged by the study coordinator to negate or camouflage the effects of the test product;
- Taking anti-inflammatory medications on a daily basis (81 mg aspirin is acceptable);
- Use of oral, inhaled or injected steroid medication within the last 6 months (for example: prednisone, dexamethasone). Nasal sprays for allergies are allowed;
- Any other significant disease or disorder that the investigator judges may put the subject at risk because of participation in the study, or may influence the result of the study;
- Any other condition or observation that the investigator judges may adversely affect the person's ability to complete the study;
- Women of child-bearing potential: Pregnant, breast-feeding, or trying to become pregnant;
- Known allergies to ingredients in the test and placebo products.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Prickly pear juice
Prickly pear juice, 3 oz daily for 8 weeks.
|
3 ounces daily for 8 weeks.
|
|
Placebo Comparator: Pear-flavored juice
Pear-flavored juice, 3 oz daily for 8 weeks.
|
3 ounces daily for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain level
Time Frame: Baseline, 2 weeks, and 8 weeks.
|
Pain questionnaire: Scale 0-10, with 0 being pain-free and 10 being the most pain.
Change from baseline will be evaluated.
|
Baseline, 2 weeks, and 8 weeks.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Range of motion
Time Frame: Baseline and 8 weeks.
|
Digital inclinometry for measuring mobility of neck, back, hips, knees, and shoulders.
|
Baseline and 8 weeks.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Gitte Jensen, NIS Labs
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- NIS114012
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.